Cantor Fitzgerald’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-93,480
Closed -$3.3K 409
2025
Q2
$3.3K Hold
93,480
﹤0.01% 439
2025
Q1
$3.08K Hold
93,480
﹤0.01% 302
2024
Q4
$3.75K Hold
93,480
﹤0.01% 262
2024
Q3
$7.48K Hold
93,480
﹤0.01% 195
2024
Q2
$4.67K Hold
93,480
﹤0.01% 233
2024
Q1
$8.43K Hold
93,480
﹤0.01% 234
2023
Q4
$1.87K Hold
93,480
﹤0.01% 234
2023
Q3
$8.32K Hold
93,480
﹤0.01% 517
2023
Q2
$4.67K Hold
93,480
﹤0.01% 545
2023
Q1
$3.52K Hold
93,480
﹤0.01% 654
2022
Q4
$4K Hold
93,480
﹤0.01% 677
2022
Q3
$3K Hold
93,480
﹤0.01% 755
2022
Q2
$12K Hold
93,480
﹤0.01% 771
2022
Q1
$22K Buy
93,480
+49,853
+114% +$21.5K ﹤0.01% 368
2021
Q4
$34K Buy
+43,627
New +$32K ﹤0.01% 359

Other funds holding COCHW

Cantor Fitzgerald's COCHW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Envoy Medical Warrant (COCHW) in Q3 2025, closing a stake of 93,480 shares — an estimated $3.3K sold.

Cantor Fitzgerald first reported a position in COCHW in Q4 2021 and held it in 15 quarters. The position peaked at $34K in Q4 2021. 36 funds tracked by Wall St. Rank hold COCHW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Envoy Medical Warrant position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 93,480 Envoy Medical Warrant shares in Q3 2025, an estimated $3.3K.
  • Cantor Fitzgerald first reported a position in Envoy Medical Warrant in Q4 2021 and held it in 15 quarters.
  • Cantor Fitzgerald's Envoy Medical Warrant position peaked at $34K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.